
|Articles|July 1, 2018
- Pharmaceutical Executive-07-01-2018
- Volume 38
- Issue 7
Pharmaceutical Executive, July 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Opioid Litigation: Evading the Widening Crosshairsabout 8 years ago
Patient & Customer-Centric Commercializationabout 8 years ago
Compliance: The Critical Cog in Pharma Machineabout 8 years ago
Gaining Ground with Stem Cells: Gil Van Bokkelen, Athersysabout 8 years ago
A Seat at the Strategy Tableabout 8 years ago
Regulatory Innovation Generates Breakthroughsabout 8 years ago
China’s Biopharma Rise: Opportunities and ThreatsAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Bristol Myers Squibb Expands Collaboration with Nvidia to Build AI Factory
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
Staying Ahead of Viral Evolution: Q&A with Robert Allen, Ph.D
5




